Sort
16,300 grants matching “fatty liver disease”
Corticosteroid Pharmacokinetics and Pharmacodynamics
$720,690William J Jusko · State University Of New York At Buffalo · R01 · FY2015 · GM
Automated quantification of lipid droplets in fatty liver tissue sections
$720,643Patrick M McDonough · Vala Sciences, Inc. · R42 · FY2012 · DK
Role of Peripheral Insulin Resistance and Inflammation in Alzheimerâs Disease
$720,621Jason K Kim · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AG
Atheroprotective Gene Therapy
$720,435David A Dichek · University Of Washington · R01 · FY2020 · HL
Atheroprotective Gene Therapy
$720,435David A Dichek · University Of Washington · R01 · FY2022 · HL
Atheroprotective Gene Therapy
$720,435David A Dichek · University Of Washington · R01 · FY2021 · HL
Mechanism and inhibition of SREBP-dependent cholesterol/lipid metabolism
$720,423Gerhard Wagner · Harvard Medical School · R01 · FY2014 · HL
Predictors of Youth-Onset Type 2 Diabetes: UAB Clinical Center
$720,293Barbara A. Gower · University Of Alabama At Birmingham · U01 · FY2024 · DK
Gut Microbiota-Mediated Inflammatory Interactions Between Alcohol Use Disorders and HIV Infection
$720,080Ali Keshavarzian · Rush University Medical Center · R01 · FY2025 · AA
Caregivers as the Agent of Change for Childhood Obesity and Chronic Disease Risk Among Latino Families
$720,068Kerri N Boutelle · Children'S Hospital Of Los Angeles · P50 · FY2025 · MD
Epigenetics of Development
$719,943Brant Weinstein · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Southern California Children's Enviromental Health Center (SC-CEHC)
$719,938Rob S McConnell · University Of Southern California · P01 · FY2016 · ES
Discovery of Pharmacogenomic Biomarkers for Metformin Response
$719,085Kathleen M Giacomini · University Of California, San Francisco · R01 · FY2017 · GM
Gut Microbiota-Mediated Inflammatory Interactions Between Alcohol Use Disorders and HIV Infection
$718,494Ali Keshavarzian · Rush University Medical Center · R01 · FY2024 · AA
Functions of vitamin E and the tocopherol transfer protein
$718,422Danny Manor · Case Western Reserve University · R01 · FY2021 · DK
CVD in American Indians Biomarker lab and Arizona Field Center
$718,329Jason G Umans · Medstar Health Research Institute · R01 · FY2017 · HL
CVD in American Indians Biomarker lab and Arizona Field Center
$718,329Jason G Umans · Medstar Health Research Institute · R01 · FY2016 · HL
Alcohol Metabolism, Functional Consequence And Signaling Mechanism
$718,210Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA
Development of caspase-6 inhibitors for treatment of NASH
$717,397Alan R. Saltiel · University Of California, San Diego · R01 · FY2023 · DK
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$716,714Ryan Eugene Temel · University Of Kentucky · R01 · FY2014 · HL
Southern California Children's Enviromental Health Center (SC-CEHC)
$716,485Rob S McConnell · University Of Southern California · P01 · FY2017 · ES
Research to Improve and Standardize Marmoset Nutrition and Dietary Husbandry
$716,130Suzette D Tardif · Texas Biomedical Research Institute · R24 · FY2016 · OD
Genetic Susceptibility to Adverse Metabolic Consequences of Obesity
$715,920Jonathan C Cohen · Ut Southwestern Medical Center · RL1 · FY2011 · HL
Studies of the Function of Naturally Occurring and Adaptive T Regulatory Cells
$715,819Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Epigenetic markers of severity in nonalcoholic fatty liver disease
$715,550Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2019 · DK